Cytosorbents Corp

H.C. Wainwright Reiterates Positive Outlook On Cytosorbents; Sees 47% Upside

In a research report released on Tuesday, H.C.

Ben Mahaney, Editor — January 27, 2015, 3:49 PM EDT

Brean Capital Comments On Cytosorbents Following Public Offering

In a research report released this morning, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Cytosorbents Corp (NASDAQ:CTSO) with a $25 price …

Jason Cohen Jason Cohen — January 20, 2015, 11:21 AM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts